We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+2.35%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.89B
AUM Growth
-$158M
Cap. Flow
-$287M
Cap. Flow %
-3.63%
Top 10 Hldgs %
74.12%
Holding
84
New
2
Increased
15
Reduced
23
Closed
7

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$24M
2
BABA icon
Alibaba
BABA
+$16.7M
3
SRPT icon
Sarepta Therapeutics
SRPT
+$3.54M
4
ALGN icon
Align Technology
ALGN
+$3.42M
5
HDB icon
HDFC Bank
HDB
+$3.33M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$135M
2
ECL icon
Ecolab
ECL
+$38.8M
3
BIDU icon
Baidu
BIDU
+$28.6M
4
TMO icon
Thermo Fisher Scientific
TMO
+$26M
5
XOM icon
ExxonMobil
XOM
+$20.9M

Sector Composition

Rank Sector Weight
1 Financials 22.39%
2 Consumer Discretionary 17.21%
3 Healthcare 13.13%
4 Consumer Staples 11.8%
5 Communication Services 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
26
Edwards Lifesciences
EW
$49.6B
$21.1M 0.27%
287,241
-75,588
-21% -$5.31M
ILMN icon
27
Illumina
ILMN
$31B
$17.6M 0.22%
59,601
+3,570
+6% +$1.05M
DXCM icon
28
DexCom
DXCM
$31.5B
$16.5M 0.21%
440,960
-46,836
-10% -$1.82M
PODD icon
29
Insulet
PODD
$11.5B
$16.4M 0.21%
99,672
-53,000
-35% -$7.45M
CHRS icon
30
Coherus Oncology
CHRS
$217M
$16.4M 0.21%
808,464
+130,000
+19% +$2.6M
EXAS
31
DELISTED
Exact Sciences
EXAS
$16.2M 0.21%
178,932
– –
TDOC icon
32
Teladoc Health
TDOC
$1.22B
$15.9M 0.2%
234,834
– –
TFX icon
33
Teleflex
TFX
$6.05B
$15.3M 0.19%
45,000
– –
HUM icon
34
Humana
HUM
$43.7B
$14.1M 0.18%
55,000
– –
CNC icon
35
Centene
CNC
$30.7B
$13.7M 0.17%
317,306
– –
BHVN
36
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$13M 0.16%
311,751
– –
HRTX icon
37
Heron Therapeutics
HRTX
$93.9M
$13M 0.16%
702,069
– –
TVRD
38
Tvardi Therapeutics
TVRD
$19.7M
$12.9M 0.16%
19,541
– –
LHCG
39
DELISTED
LHC Group LLC
LHCG
$12.6M 0.16%
110,657
– –
NVCR icon
40
NovoCure
NVCR
$1.73B
$12.5M 0.16%
166,784
-41,275
-20% -$3.3M
VRTX icon
41
Vertex Pharmaceuticals
VRTX
$121B
$11.6M 0.15%
68,557
– –
TXMD icon
42
TherapeuticsMD
TXMD
$23.5M
$11.6M 0.15%
63,797
– –
AMRN
43
Amarin Corp
AMRN
$299M
$11.5M 0.15%
38,066
– –
BMRN icon
44
BioMarin Pharmaceuticals
BMRN
$11.6B
$11M 0.14%
163,851
– –
SRPT icon
45
Sarepta Therapeutics
SRPT
$1.57B
$10.9M 0.14%
145,329
+30,000
+26% +$3.54M
AERI
46
DELISTED
Aerie Pharmaceuticals
AERI
$10.7M 0.14%
556,142
+100,000
+22% +$2.29M
ALGN icon
47
Align Technology
ALGN
$12.1B
$10.6M 0.13%
58,428
+16,428
+39% +$3.42M
GKOS icon
48
Glaukos
GKOS
$9.83B
$10.5M 0.13%
167,212
-42,053
-20% -$2.96M
STML
49
DELISTED
Stemline Therapeutics, Inc.
STML
$10.4M 0.13%
998,677
+140,595
+16% +$1.84M
AXDX
50
DELISTED
Accelerate Diagnostics
AXDX
$9.74M 0.12%
52,468
– –
1
2
3 4

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
DWM
Dakota Wealth Management Palm Beach Gardens, Florida $4.62B AUM 33.09% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return

C WorldWide Group's Q3 2019 Portfolio in Review

As of Q3 2019, C WorldWide Group held 84 positions worth $7.89B, down 2% from $8.04B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

C WorldWide Group withdrew a net $287M in Q3 2019, closing 7 positions and reducing 23 holdings. Its most notable exit was Baidu, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, C WorldWide Group opened a new position in TJX Companies worth $1.03M.

  • C WorldWide Group's largest Q3 2019 buy was TJX Companies: 18,566 shares worth $1.03M.
  • C WorldWide Group added most to Procter & Gamble in Q3 2019, an estimated $24M increase.
  • C WorldWide Group's biggest Q3 2019 reduction was Visa, cutting an estimated $135M.
  • C WorldWide Group fully exited Baidu in Q3 2019, selling an estimated $28.6M.
  • C WorldWide Group's ten largest holdings make up 74% of its $7.89B portfolio in Q3 2019.
  • C WorldWide Group opened 2 new positions and closed 7 in Q3 2019.
  • C WorldWide Group's portfolio value fell 2% quarter-over-quarter to $7.89B.

Based on C WorldWide Group's 13F filing for Q3 2019, filed 4 Nov 2019.